Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Diagnosed Between 1991 and 2013

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|12|3270-3278

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.12, 2015-12, pp. : 3270-3278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Juvenile Slow Progressive Antineutrophil Cytoplasmic Antibody‐Associated Vasculitis Diagnosed After Kidney Transplantation: A Case Report

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 3, 2015-06 ,pp. : 303-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody‐associated vasculitis

By  

NEPHROLOGY, Vol. 20, Iss. 5, 2015-05 ,pp. : 343-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Outcome and Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Japan

By  

Nephron Clin Pract, Vol. 115, Iss. 1, 2010-02 ,pp. : c21-c27

Karger

Access to resources Recommend Favorite

Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3151-3159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Peripheral CD5+ B Cells in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 2, 2015-02 ,pp. : 535-544

John Wiley & Sons Inc

Access to resources Recommend Favorite